Esomeprazole and omeprazole might boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) bringing about improved adverse effects such as drowsiness, although the scientific relevance is small for most people – observe the client for adverse effects (e. If patient are unable to resume their typical oral medication article-op